Long noncoding RNAs in cancer cells

Cancer Lett. 2018 Apr 10:419:152-166. doi: 10.1016/j.canlet.2018.01.053.

Abstract

Long noncoding RNA (lncRNA) has recently been investigated as key modulators that regulate many biological processes in human cancers via diverse mechanisms. LncRNAs can interact with macromolecules such as DNA, RNA, or protein to exert cellular effects and to act as either tumor promoters or tumor suppressors in various malignancies. Moreover, the aberrant expression of lncRNAs may be detected in multiple cancer phenotypes by employing the rapidly developing modern gene chip technology and bioinformatics analysis. Herein, we highlight the mechanisms of action of lncRNAs, their functional cellular roles and their involvement in cancer progression. Finally, we provide an overview of recent progress in the lncRNA field and future potential for lncRNAs as cancer diagnostic markers and therapeutics.

Keywords: Cancer biomarker; Drug-resistance; Hallmarks of cancer; Oncogene; lncRNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Disease Progression
  • Gene Expression Regulation, Neoplastic*
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Models, Genetic
  • Mutation
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding